Neuronetics Prices 8 Million Share Offering at $2.25; $18 Million Raised Amid 34% Pre-Market Drop

Neuronetics Inc. has announced an underwritten public offering of common stock, pricing 8 million shares at $2.25 each, totaling $18 million. The offering comes as Neuronetics' stock is down 34% in pre-market trading. In a related development, Sionna Therapeutics, Inc. has priced its upsized initial public offering (IPO) at $18 per share, raising $10.6 million, which is an increase from the previously planned $8.8 million. Sionna is set to debut on NASDAQ on Friday. The IPO market remains active, with a total of six IPOs expected this week, including Sionna and other companies in various sectors.